Target intelligence / Profile preview

Bacterial denitrification pathway (None)

Target
None
Molecular classification
Enzyme pathway, Respiration pathway
01

Overview

The bacterial denitrification pathway is a stepwise respiratory process in which bacteria reduce nitrate (NO₃⁻) to dinitrogen gas (N₂) via intermediates nitrite (NO₂⁻), nitric oxide (NO), and nitrous oxide (N₂O), primarily using four enzyme systems: nitrate reductase, nitrite reductase, nitric oxide reductase, and nitrous oxide reductase. This process allows bacteria to generate energy in oxygen-poor environments and plays a central role in global nitrogen cycling, environmental nitrogen removal, and greenhouse gas emissions. Individual enzymes, not the pathway as a whole, may be considered distinct drug targets or biomarkers in clinical and research settings.

Other names
Denitrificationmicrobial denitrificationnitrogen oxide reduction pathway
02

Mechanism of action

For enzyme inhibitors within the pathway: competitive or non-competitive inhibition of the enzyme's active site, blocking electron transfer and nitrogen oxide reduction

03

Biological functions

Nitrogen cycling (conversion of nitrate to nitrogen gas)Bioenergetics (energy conservation for bacteria under anaerobic or microaerophilic conditions)Environmental adaptation (enables bacteria to survive in oxygen-depleted environments)
04

Disease associations

Infection (certain pathogenic bacteria possess denitrification pathways, relevant in host environments or antimicrobial drug development)Other (agricultural and environmental relevance due to roles in nitrogen leaching, wastewater treatment, and greenhouse gas production)
05

Safety considerations

The pathway itself produces nitrous oxide (N₂O), a potent greenhouse gas and ozone-depleting substance, which is an environmental safety concernManipulation of bacterial denitrification in the human microbiome or soil may impact nitrogen cycling, pathogen survival, or antimicrobial resistance
06

Interacting drugs

None specific to the entire pathway; inhibitors exist for some enzymes (e.g., inhibitors of nitrate reductase, nitrite reductase, etc.), but these are used mostly in experimental or agricultural contexts and not as approved therapies
07

Biomarkers

Genes encoding pathway enzymes (narG, napA, nirK, nirS, norB, norC, norV, nosZ) are used as biomarkers for denitrification potential and activity in environmental, microbial, or clinical samples

Beyond the preview

Go deeper on Bacterial denitrification pathway (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial denitrification pathway (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call